Acquired Expansion Euticals was acquired by AMRI in 2017, indicating a potential opportunity to engage through AMRI’s network for API development and manufacturing services, as well as possible integration projects or capacity expansions.

Mid-sized Focus With 51-200 employees and revenue in the mid single to low tens of millions, Euticals represents a mid-market target for scalable API and pharmaceutical intermediate production services, suitable for add-on capacity or selective outsourcing partnerships.

Energy Management The 2015 launch of an energy management system signals openness to efficiency improvements and sustainability initiatives, suggesting possible interest in energy optimization, green chemistry collaborations, or utility cost-reduction projects.

Global Footprint Despite being a smaller group, Euticals had global-scale production and multiple sites, implying opportunities for integrated supply chain solutions, quality compliance support, and regional manufacturing partnerships.

Technology Stack Current tech stack includes Joomla, MooTools, jQuery, PHP and analytics tools, indicating potential partnerships around digital transformation, GMP-compliant data systems, and modernization of IT/automation for manufacturing operations.